Clarissa Parker to Combined Modality Therapy
This is a "connection" page, showing publications Clarissa Parker has written about Combined Modality Therapy.
Connection Strength
0.089
-
Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial. J Clin Oncol. 2004 Nov 01; 22(21):4341-50.
Score: 0.024
-
Brain metastases. Curr Treat Options Oncol. 2001 Dec; 2(6):537-47.
Score: 0.020
-
The role of induction therapy in the management of resectable non-small cell lung cancer. Cancer Control. 2000 Jan-Feb; 7(1):45-55.
Score: 0.017
-
Combined-modality therapy in the nonsurgical management of unresectable stage III non-small cell lung cancer. Curr Opin Pulm Med. 1999 Jul; 5(4):194-200.
Score: 0.017
-
Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol. 2004 Dec 01; 22(23):4837-45.
Score: 0.012